The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
A summary of the landmark trials that show that careful blood glucose management can lower the risk of long-term health complications in people with type 1 or type 2 diabetes Continue Reading »
The microbiome is an exciting area of research for diabetes management. What do we know and what questions do we still have about the microbiome? Continue Reading »
What is the link between vision loss and mental health outcomes, and how can eye exams tell us what is going on in the brain and the body? Continue Reading »
dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they spend in range daily Continue Reading »
Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications Continue Reading »
The first study of people with diabetes and COVID-19 reveals troubling statistics and risk factors Continue Reading »
In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13 Continue Reading »
Check out the third day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on off label use in type 1 diabetes, type 2 diabetes remission, DIY closed loop, DSMES, and more! Continue Reading »
